Factors Predicting Outcome for Advanced Gastroesophageal Cancer in Elderly Patients Receiving Palliative Chemotherapy

Clinical Oncology

Volumn 22, Issue 2, 2010, Pages 107-113

  Lord, S R ^a   Hall, P S ^b   McShane, P ^b   Brown, J ^b   Seymour, M T ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; MITOMYCIN C;

ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CONTROLLED STUDY; DRUG CHOICE; DRUG DOSE REDUCTION; ELDERLY CARE; ESOPHAGUS CANCER; FEMALE; GASTROESOPHAGEAL CANCER; HUMAN; KARNOFSKY PERFORMANCE STATUS; LETHARGY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SYMPTOM; VULNERABLE POPULATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PALLIATIVE CARE; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 75449089679     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.12.001     Document Type: Article

References (22)

1. Cancer Research UK. CancerStats. Available from: http://info.cancerresearchuk.org/cancerstats. Accessed June 2009.
2. Kocher H.M., Linklater K., Patel S., and Ellul J.P. Epidemiological study of oesophageal and gastric cancer in south-east England. Br J Surg 88 (2001) 1249-1257
3. Scartozzi M., Galizia E., Verdecchia L., et al. Chemotherapy for advanced gastric cancer: across the years for a standard of care. Expert Opin Pharmacother 8 (2007) 797-808
4. Janunger K.G., Hafstrom L., Nygren P., and Glimelius B. A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 40 (2001) 309-326
5. Cunningham D., Starling N., Rao S., et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358 (2008) 36-46
6. Moynihan T., Hansen R., Anderson T., et al. Continuous 5-fluorouracil infusion in advanced gastric carcinoma. Am J Clin Oncol 11 (1988) 461-464
7. Kok T.C., van der Gaast A., and Splinter T.A. 5-fluorouracil and folinic acid in advanced adenocarcinoma of the esophagus or esophago-gastric junction area. Rotterdam Esophageal Tumor Study Group. Ann Oncol 7 (1996) 533-534
8. Sakamoto J., Chin K., Kondo K., et al. Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer. Anticancer Drugs 17 (2006) 231-236
9. Hong Y.S., Song S.Y., Lee S.I., et al. A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer. Ann Oncol 15 (2004) 1344-1347
10. Levi F., Lucchini F., Negri E., et al. Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol 14 (2003) 490-495
11. Edwards B.K., Howe H.L., Ries L.A., et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94 (2002) 2766-2792
12. Polee M.B., Hop W.C., Kok T.C., et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer 89 (2003) 2045-2050
13. Chau I., Norman A.R., Cunningham D., et al. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 22 (2004) 2395-2403
14. Popescu R.A., Norman A., Ross P.J., et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol 17 (1999) 2412-2418
15. Meta-Analysis Group in Cancer. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Cancer J Clin Oncol 16 (1998) 3537-3541
16. Stein B.N., Petrelli N.J., Douglass H.O., et al. Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial. Cancer 75 (1995) 11-17
17. Accessed (February 2009), National Cancer Intelligence Network, UK. http://www.ncis.org.uk
18. Trumper M., Ross P.J., Cunningham D., et al. Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: a pooled analysis of three clinical trials. Eur J Cancer 42 (2006) 827-834
19. Folprecht G., Cunningham D., Ross P., et al. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol 15 (2004) 1330-1338
20. Wagner A.D., Grothe W., Haerting J., et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 24 (2006) 2903-2909
21. Crosby T. Scottish Intercollegiate Guidelines Network (SIGN) 87-The management of oesophageal and gastric cancer. Clin Oncol (R Coll Radiol) 20 (2008) 528-529
22. Alderson D. Scottish Intercollegiate Guidelines Network (SIGN) 87-The management of oesophageal and gastric cancer. Clin Oncol (R Coll Radiol) 20 (2008) 530-531